Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Types include open adrenalectomy, laparoscopic adrenalectomy, and robotic-assisted adrenalectomy, depending on the size and location of the condition being treated.

A positive result suggests exposure to Treponema pallidum, the bacterium causing syphilis. Further tests are needed to confirm the diagnosis.

No, the VDRL test detects antibodies to Treponema pallidum, which may persist even after successful treatment. Additional tests may be required for confirmation.

Yes, routine VDRL testing during pregnancy helps detect and treat syphilis early to prevent transmission to the fetus.

No specific precautions are necessary. Follow any instructions provided by your healthcare provider based on your results.

Consult a healthcare provider for further evaluation, as additional tests or clinical assessment may be necessary.